Virtual Library

Start Your Search

  • ELCC 2017

    The 7th European Lung Cancer Conference

    Access to all presentations that took place at ELCC 2017 in Geneva, Switzerland

    Presentation Date(s):  
    • May 5 – 8, 2017
    • Total Presentations: 359

Filter Results:

Show Only Available Presentations

  • +

    Management of non-oncogene driven NSCLC

    • Type: Specialty Session
    • Presentations: 5
    • +

      Second line treatment and beyond: Selecting new agents in the arena for subsequent therapy

      11:40 - 12:00  |  Author(s): L. Horn

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    Targeted therapies and management of brain metastasis

    • Type: Proffered Paper session
    • Presentations: 7
    • Moderators:D.P. Carbone
    • Coordinates: 5/06/2017, 16:45 - 18:15, Room A
  • +

    Management of NSCLC with resistance to first line targeted therapy

    • Type: Educational session
    • Presentations: 5
    • Moderators:L. Horn
    • Coordinates: 5/07/2017, 09:00 - 10:30, Room B
    • +

      Management of T790M positive disease after EGFR TKI failure

      09:00 - 09:20  |  Author(s): L. Horn

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Management of T790M negative disease after EGFR TKI failure

      09:20 - 09:40  |  Author(s): M. Krebs

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Management of drug resistance in ALK positive NSCLC

      09:40 - 10:00  |  Author(s): D.S. Tan

      • Abstract

      No abstract available for this presentation

    • +

      Management of resistance in other targets beyond ALK and EGFR

      10:00 - 10:20  |  Author(s): L. Friboulet

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Questions and Answers

      10:20 - 10:30

      • Abstract

      No abstract available for this presentation

  • +

    Poster Display Session

    • Type: Poster Display Session
    • Presentations: 142
    • Coordinates: 5/07/2017, 12:30 - 13:00, Hall 1
    • +

      58TiP - IMpower133: Phase I/III trial of first-line atezolizumab with carboplatin and etoposide in ES-SCLC

      12:30 - 12:30  |  Author(s): M. Reck

      • Abstract

      Loading...

    • +

      146TiP - EXalt3: A phase III study of ensartinib (X-396) in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC)

      12:30 - 12:30  |  Author(s): L. Horn

      • Abstract

      Loading...

  • +

    Targeted therapies and immunotherapies

    • Type: Poster Discussion session
    • Presentations: 10
    • Moderators:S. Ekman
    • Coordinates: 5/07/2017, 14:45 - 15:45, Room W
    • +

      91PD_PR - Response to salvage chemotherapy following exposure to PD-1/PD-L1 inhibitors in patients with NSCLC

      14:45 - 14:45  |  Author(s): S.I. Rothschild

      • Abstract

      Loading...